FIELD: medicine; experimental medicine and neurology.
SUBSTANCE: invention can be used in the treatment of the brain in acute hypoxia with hypercapnia. The method includes oral administration of a protective agent. Meconic acid is used as a protective agent in an amount of 2 to 4 mg/kg of body weight daily for 3–4 days.
EFFECT: use of the invention makes it possible to prevent oxidative damage to brain tissues caused by acute hypoxia with hypercapnia by increasing the level of reduced glutathione (GSH) in the brain.
1 cl, 4 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREVENTING AND CORRECTING METABOLIC AND FUNCTIONAL DISORDERS OF THE CENTRAL NERVOUS SYSTEM UNDER STRESS CONDITIONS | 2019 |
|
RU2717107C1 |
| ANTIOXIDANT, STRESS- AND NEUROPROTECTIVE PHARMACOLOGICAL AGENT POTASSIUM COMENATE | 2012 |
|
RU2514632C1 |
| NATURAL PHOSPHOLIPID AGENT | 2008 |
|
RU2367443C1 |
| AGENT POSSESSING ANTIRADICAL, CEREBROPROTECTIVE AND ANTIISCHEMIC PROPERTIES | 2010 |
|
RU2445090C1 |
| ANTIOXIDANT, STRESS AND NEUROPROTECTIVE PHARMACOLOGICAL AGENT SODIUM COMENATE | 2012 |
|
RU2506078C1 |
| NEUROPROTECTIVE PHARMACEUTICAL AGENT | 2013 |
|
RU2528914C1 |
| PHARMACOLOGICAL NEUROPROTECTIVE DRUG | 2014 |
|
RU2561045C1 |
| METHOD FOR PREPARING LITHIUM SALT OF COMENIC ACID AND USING IT AS ANTIOXIDANT, STRESS- AND NEUROPROTECTIVE AGENT | 2011 |
|
RU2477722C1 |
| USE OF L-CARNOSINE FOR PRODUCING NANOPREPARATION POSSESSING ANTIHYPOXIC AND ANTIOXIDANT ACTIVITY | 2012 |
|
RU2482867C1 |
| AGENT FOR DISEASES ASSOCIATED WITH STRESS-RELATED CONDITIONS IN DISEASES AND DISORDERS IN HUMAN AND ANIMALS, AND ALSO METHOD OF TREATING AND/OR PREVENTING WITH USING SUCH AGENT | 2009 |
|
RU2450823C2 |
